8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Pooled results from many studies on one question.
2019 / Umbrella review of meta-analyses of observational studies
An umbrella review examined 96 meta-analyses covering 40 unique health outcomes to assess associations with tea consumption. An increment of two to three cups per day was associated with reduced risks of total mortality, cardiac death, coronary artery disease, stroke, and type 2 diabetes mellitus, alongside beneficial associations for several cancers, skeletal, cognitive, and maternal outcomes. Harmful associations were identified for esophageal and gastric cancer when tea was consumed at temperatures above 55-60 °C. The authors state that randomized controlled trials are needed to determine causality.
Shows an association, not proof of cause and effect.
Yi M, Wu X, Zhuang W, et al. Mol Nutr Food Res, 2019. PMID 31216091
2019 / Meta-analysis of prospective cohorts
A meta-analysis evaluated 23 prospective cohorts involving 330,826 participants. Intake of soy products was inversely associated with cancer mortality (RR 0.88, 95% CI 0.79 to 0.99) and cardiovascular mortality (ES 0.85, 95% CI 0.72 to 0.99). Additionally, each 10-mg daily increment of soy isoflavones was linked to lower risk of death from all cancers and breast cancer, while soy protein was not tied to all-cause mortality.
Shows an association, not proof of cause and effect.
Nachvak SM, Moradi S, Anjom-Shoae J, et al. J Acad Nutr Diet, 2019. PMID 31278047
2019 / Systematic review and meta-analysis of observational studies
A systematic review and meta-analysis of 11 case-control and case-cohort studies evaluated the relationship between dietary phytosterols and cancer risk. Comparing highest versus lowest intake, the summary relative risk was 0.63 (95% CI = 0.49-0.81) for total phytosterols and 0.77 (95% CI = 0.65-0.90) for campestanol. Relative risks for other phytosterols were 0.74 (95% CI = 0.54-1.02) for β-sitosterol, 0.72 (95% CI = 0.51-1.00) for campesterol, 0.83 (95% CI = 0.60-1.16) for stigmasterol, and 1.12 (95% CI = 0.96-1.32) for β-sitostanol. Dose-response analyses indicated a linear association for campesterol and a nonlinear association for total phytosterols.
Shows an association, not proof of cause and effect.
Jiang L, Zhao X, Xu J, et al. J Oncol, 2019. PMID 31341477
2019 / Systematic review
A systematic review was conducted across PubMed/MEDLINE, Cochrane Central Register of Controlled Trials, and EMBASE for studies published between October 2007 and September 2018 evaluating yoga-based interventions for breast cancer-related lymphedema. An 8-week yoga intervention yielded significant improvements in lymphedema status, range of shoulder motion, and spinal mobility, but quality of life results were inconsistent. Long-term yoga practice showed no difference in lymphedema status, extracellular fluid, or tissue resistance outcomes in the affected arm. The authors concluded that findings could not clearly demonstrate that yoga added to usual care is superior to usual care alone, and ongoing yoga exercise did not provide significant added benefits.
Wei CW, Wu YC, Chen PY, et al. Complement Ther Clin Pract, 2019. PMID 31383443
2019 / Meta-analysis
A meta-analysis of 22 studies involving 1,409 patients evaluated Astragalus-based Chinese medicines combined with chemotherapy versus chemotherapy alone for colorectal cancer. The combination was associated with an increased tumor response rate (RR: 1.52; 95% CI: 1.24-1.87; p < 0.0001) and improved quality of life on the KPS scale (RR: 2.51; 95% CI: 1.85-3.42; p < 0.00001). It also reduced adverse reactions such as neutropenia, anemia, thrombocytopenia, nausea/vomiting, diarrhea, and neurotoxicity, while hepatic and renal dysfunction did not differ significantly between groups.
Lin S, An X, Guo Y, et al. Front Oncol, 2019. PMID 31456940
2019 / Systematic review and meta-analysis of cohort studies
A systematic review and meta-analysis of 118 articles (56 cohorts) with more than 6 million participants assessed meat intake and cancer outcomes. Low-certainty evidence suggested reducing unprocessed meat by 3 servings per week was associated with a very small lifetime reduction in overall cancer mortality. Evidence of low to very low certainty suggested reducing processed meat by 3 servings per week was associated with very small decreases in overall cancer mortality, prostate cancer mortality, and incidence of esophageal, colorectal, and breast cancer. Limitations included residual confounding, risk of bias from diet assessment and confounder adjustment, recall bias, and insufficient subgroup data.
Shows an association, not proof of cause and effect.
Han MA, Zeraatkar D, Guyatt GH, et al. Ann Intern Med, 2019. PMID 31569214
2019 / Systematic review and meta-analysis of prospective cohorts
Reviewers synthesized prospective cohort studies following participants for 2 to 34 years to evaluate dietary patterns with varying red and processed meat content. Low- to very-low-certainty evidence indicated that patterns lower in red and processed meat were linked to very small decreases in all-cause mortality, cardiovascular mortality, cancer mortality, and type 2 diabetes. Total sample sizes ranged from 4,000 to over 400,000 individuals across outcomes.
Shows an association, not proof of cause and effect.
Vernooij RWM, Zeraatkar D, Han MA, et al. Ann Intern Med, 2019. PMID 31569217
2019 / Meta-analysis of randomized controlled trials
A meta-analysis of 10 randomized controlled trials with 81,362 participants evaluated the effect of vitamin D supplementation on cancer incidence and mortality. Cancer incidence was 9.16% in the vitamin D group versus 9.29% in the placebo group, showing no significant difference (RR 0.99, 95% CI: 0.94-1.03, P=0.532). Cancer mortality was significantly lower with vitamin D (2.11% vs. 2.43%; RR 0.87, 95% CI: 0.79-0.95, P=0.003). Subgroup analyses indicated that a history of cancer, extra vitamin D use, and calcium supplementation were potential sources of heterogeneity.
Zhang X, Niu W Biosci Rep, 2019. PMID 31696224
2018 / Umbrella review of meta-analyses
An umbrella review analyzed 13 meta-analyses of observational studies and 16 meta-analyses of RCTs assessing adherence to the Mediterranean diet across 37 health outcomes in over 12,800,000 subjects. Robust evidence (P < 0.001, large sample size, and not considerable heterogeneity) supported an association between greater adherence and reduced risks of overall mortality, cardiovascular diseases, coronary heart disease, myocardial infarction, overall cancer incidence, neurodegenerative diseases, and diabetes. Evidence was only suggestive or weak for most site-specific cancers, inflammatory, and metabolic parameters. No evidence was reported for bladder, endometrial, and ovarian cancers, or LDL-cholesterol levels.
Shows an association, not proof of cause and effect.
Dinu M, Pagliai G, Casini A, et al. Eur J Clin Nutr, 2018. PMID 28488692
2018 / Dose-response meta-analysis of cohort studies
A meta-analysis of six studies including 5,984 breast cancer patients explored the dose-response relationship between circulating 25-hydroxyvitamin D levels and overall survival. Comparing the highest with the lowest vitamin D category yielded a pooled hazard ratio of 0.67 (95% CI: 0.56-0.79, P < .001). A linear dose-response analysis found a pooled hazard ratio for overall survival of 0.994 per 1 nmol/L (P for linear trend < .001), with increments of 10, 20, or 25 nmol/L at or above 23.3 nmol/L associated with 6%, 12%, and 14% lower risks of overall mortality. Authors note that better designed prospective cohort studies and clinical trials are needed to confirm these findings.
Shows an association, not proof of cause and effect.
Hu K, Callen DF, Li J, et al. Integr Cancer Ther, 2018. PMID 28589744
2018 / Systematic review and dose-response meta-analysis
A meta-analysis of 19 cohort studies including 1,041,692 participants and 96,710 deaths evaluated whole grain intake and mortality risk. Comparing highest versus lowest intake categories showed pooled relative risks of 0.84 (95% CI 0.81-0.88) for all-cause, 0.83 (95% CI 0.79-0.86) for cardiovascular, and 0.94 (95% CI 0.87-1.01) for cancer mortality. Each 28 g/day intake was associated with relative risks of 0.91, 0.86, and 0.97 for total, cardiovascular, and cancer mortality, respectively.
Zhang B, Zhao Q, Guo W, et al. Eur J Clin Nutr, 2018. PMID 29091078
2018 / Systematic review
Researchers identified six case series and reports comprising 39 participants with glioma, with no randomized clinical trials found. All included reports documented overall survival or progression-free survival, but each carried a high risk of bias. Because of the low-quality evidence, the clinical effectiveness of ketogenic dietary therapies for gliomas could not be determined.
Martin-McGill KJ, Srikandarajah N, Marson AG, et al. CNS Oncol, 2018. PMID 29658772
2018 / Systematic review and meta-analysis
A systematic review and meta-analysis evaluated the association between maté consumption and upper aerodigestive tract (UADT) cancer. Overall, maté consumption was associated with increased odds of UADT cancer (OR = 2.24; 95% CI = 1.74-2.87), with consistent positive associations across oral, pharyngeal, esophageal, and laryngeal subsites. Consuming more than one liter per day vs less than one liter was linked to higher odds of UADT cancer (OR = 1.72; 95% CI = 1.47-2.01), whereas no differences were detected between cold/warm and hot/very hot maté (OR = 1.08; 95% CI = 0.83-1.41).
Shows an association, not proof of cause and effect.
Mello FW, Scotti FM, Melo G, et al. Oral Oncol, 2018. PMID 29909900
2018 / Systematic review and meta-analysis
A systematic review and meta-analysis of 14 articles including 8,097 lung cancer patients examined serum one-carbon metabolism factors. Compared with controls, lung cancer patients had lower serum folate (SMD -0.53, 95% CI -0.70 to -0.35, p = 0.001) and vitamin B6 (SMD -0.28, 95% CI -0.53 to -0.02, p = 0.001), but higher homocysteine levels (SMD 0.41, 95% CI 0.24 to 0.59, p = 0.001). No significant differences were seen for vitamin B12 (SMD -0.09, 95% CI -0.27 to 0.09, p = 0.202) or methionine (SMD -0.13, 95% CI -0.36 to 0.10, p = 0.001).
Shows an association, not proof of cause and effect.
Yang J, Li H, Deng H, et al. Front Oncol, 2018. PMID 30430082
2017 / Meta-analysis of prospective cohorts
A meta-analysis evaluated 15 prospective cohort studies examining dietary fat intake and mortality among women with breast cancer. Total fat intake was not associated with breast-cancer-specific death (HR 1.14, 95% CI 0.86-1.52) or all-cause mortality (HR 1.73, 95% CI 0.82-3.66). However, the highest versus lowest intake of saturated fat was linked to higher breast-cancer-specific death (HR 1.51, 95% CI 1.09-2.09, p < 0.01).
Shows an association, not proof of cause and effect.
Brennan SF, Woodside JV, Lunny PM, et al. Crit Rev Food Sci Nutr, 2017. PMID 25692500
2017 / Systematic review and meta-analysis of observational studies
A meta-analysis of 86 cross-sectional and 10 prospective cohort studies evaluated vegetarian and vegan diets against omnivorous diets. Prospective cohorts linked vegetarian diets to lower risk of ischemic heart disease incidence or mortality (RR 0.75, 95% CI 0.68 to 0.82) and total cancer incidence (RR 0.92, 95% CI 0.87 to 0.98), but found no link to all-cause or cardiovascular mortality. Vegan diets were associated with lower total cancer incidence (RR 0.85, 95% CI 0.75 to 0.95).
Shows an association, not proof of cause and effect.
Dinu M, Abbate R, Gensini GF, et al. Crit Rev Food Sci Nutr, 2017. PMID 26853923
2017 / Systematic review and meta-analysis of cohort studies
A systematic review identified 19 cohort studies on rice intake, chronic conditions, and mortality. In a meta-analysis of 12 cohorts, comparing extreme categories of rice intake showed a non-significant trend for total chronic diseases (RR 1.11, 95% CI: 0.96 to 1.29), with an association present in women (RR 1.40, 95% CI: 1.13 to 1.73) but not men (RR 0.95, 95% CI: 0.72 to 1.24). Across five cohorts, high intake was not associated with mortality overall (RR 0.97, 95% CI: 0.88 to 1.06), but linked to lower mortality in men (RR 0.87, 95% CI: 0.81 to 0.94).
Shows an association, not proof of cause and effect.
Saneei P, Larijani B, Esmaillzadeh A Public Health Nutr, 2017. PMID 27577106
2017 / Meta-analysis of 2 cohort and 8 case-control studies
A meta-analysis evaluated the association between dietary fat intake and non-Hodgkin's lymphoma (NHL) across 10 studies (two cohort and eight case-control) using a random-effects model. Total fat consumption was significantly associated with an increased risk of NHL (RR = 1.26; 95% CI: 1.12-1.42). In subgroup analyses, intake was significantly correlated with diffuse large B-cell lymphoma (RR = 1.41; 95% CI: 1.08-1.84), but not with follicular lymphoma (RR = 1.21; 95% CI: 0.97-1.52), small lymphocytic lymphoma/chronic lymphocytic leukemia (RR = 0.91; 95% CI: 0.68-1.23), or T cell lymphoma (RR = 1.12; 95% CI: 0.60-2.09). Funnel plots showed no evidence of publication bias.
Shows an association, not proof of cause and effect.
Han TJ, Li JS, Luan XT, et al. Nutr Cancer, 2017. PMID 28094569
2017 / Umbrella review of systematic reviews and meta-analyses
Researchers conducted an umbrella review of 204 meta-analyses investigating associations between seven adiposity indices and the risk of developing or dying from 36 primary cancers and their subtypes. In primary analyses of 95 continuous-measure cohort meta-analyses, only 12 associations across nine cancers were supported by strong evidence. Risk increases per 5 kg/m2 BMI increase ranged from 9% (RR 1.09, 95% CI 1.06 to 1.13) for rectal cancer in men to 56% (RR 1.56, 95% CI 1.34 to 1.81) for biliary tract system cancer. Overall, including categorical measures, strong evidence supported associations between adiposity and only 11 cancers: oesophageal adenocarcinoma, multiple myeloma, and cancers of the gastric cardia, colon, rectum, biliary tract system, pancreas, breast, endometrium, ovary, and kidney.
Shows an association, not proof of cause and effect.
Kyrgiou M, Kalliala I, Markozannes G, et al. BMJ, 2017. PMID 28246088
2017 / Systematic review and dose-response meta-analysis of prospective studies
A systematic review and dose-response meta-analysis evaluated 95 prospective studies examining fruit and vegetable intake in relation to cardiovascular disease, cancer, and mortality. Per 200 g/day of combined fruit and vegetables, summary relative risks were 0.92 (95% CI: 0.90-0.94) for coronary heart disease, 0.84 (95% CI: 0.76-0.92) for stroke, 0.92 (95% CI: 0.90-0.95) for cardiovascular disease, 0.97 (95% CI: 0.95-0.99) for total cancer, and 0.90 (95% CI: 0.87-0.93) for all-cause mortality. Reductions in risk were observed up to 800 g/day for all outcomes except cancer (up to 600 g/day). Specific inverse associations with cardiovascular disease and mortality were reported for apples/pears, citrus fruits, green leafy vegetables, cruciferous vegetables, and salads.
Shows an association, not proof of cause and effect.
Aune D, Giovannucci E, Boffetta P, et al. Int J Epidemiol, 2017. PMID 28338764
2017 / Systematic review
A systematic review evaluated clinical evidence on isocaloric ketogenic diets in cancer patients. Evidence supporting benefits on tumor development, progression, or cancer therapy side effects was missing. In addition, multiple potential adverse effects were noted, leading authors to state that robust clinical evidence is required before recommending this diet for cancer.
Erickson N, Boscheri A, Linke B, et al. Med Oncol, 2017. PMID 28353094
2017 / Systematic review and meta-analysis
A systematic review evaluated 172 studies to assess whether milk intake influences prostate cancer via the insulin-like growth factor pathway. Moderate evidence indicated circulating IGF-I and IGFBP-3 increased with milk consumption. In meta-analyses, higher IGF-I was linked to increased prostate cancer risk (OR 1.09, 95% CI 1.03-1.16; 51 studies), while IGFBP-3 was linked to lower risk (OR 0.90, 95% CI 0.83-0.98; 39 studies).
Harrison S, Lennon R, Holly J, et al. Cancer Causes Control, 2017. PMID 28361446
2017 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis of five randomized trials examined calcium supplementation in 2,234 patients with prior colorectal adenomas. Good-quality trials showed calcium reduced recurrent adenomas (RR 0.88, 95% CI 0.79-0.99), with stronger effects at doses of at least 1,600 mg per day (RR 0.74, 95% CI 0.56-0.97), but advanced adenomas were not significantly affected (RR 1.02, 95% CI 0.67-1.55). Hypercalcemia incidence increased (P = .0095), and GRADE certainty was rated low.
Veettil SK, Ching SM, Lim KG, et al. Medicine (Baltimore), 2017. PMID 28796047
2017 / Umbrella review of meta-analyses of observational studies and RCTs
An umbrella review evaluated evidence from meta-analyses of observational studies and randomized controlled trials on coffee and caffeine consumption. Across 112 observational meta-analyses covering 59 unique outcomes, coffee was associated with a probable decreased risk of breast, colorectal, colon, endometrial, and prostate cancers, cardiovascular disease and mortality, Parkinson's disease, and type-2 diabetes. Across 20 observational meta-analyses covering 14 unique outcomes, caffeine was associated with a probable decreased risk of Parkinson's disease and type-2 diabetes, but an increased risk of pregnancy loss. Among 9 RCT meta-analyses examining 12 acute outcomes, coffee was associated with elevated serum lipids (affected by significant heterogeneity) and caffeine with elevated blood pressure.
Shows an association, not proof of cause and effect.
Grosso G, Godos J, Galvano F, et al. Annu Rev Nutr, 2017. PMID 28826374